This content is machine translated Current evidence, risk classes and new counseling options Hormonal contraception and cardiovascular risk Over 247 million women worldwide use hormonal contraception – the majority with combined oral contraceptives (COCs). This prevalence is accompanied by an ongoing medical responsibility: venous thromboembolism, ischemic strokes and...…
View Post 13 min This content is machine translated New WHO guideline, updated stimulation protocols, focus on PGT-A Fertility and reproductive medicine 2026 The year 2025 has brought several landmark documents to reproductive medicine: the first WHO guideline on the prevention, diagnosis and treatment of infertility, the major update of the ESHRE guideline...…
View Post 14 min This content is machine translated New approvals, current study data and ADC development Antibody-drug conjugates in gynecologic oncology Antibody-drug conjugates (ADCs) have profoundly changed gynecological oncology in a very short space of time. Within just two years, three ADCs – mirvetuximab soravtansine, tisotumab vedotin and trastuzumab deruxtecan –...…
View Post 22 min This content is machine translated Cervical Cancer HPV prevention, screening innovation and sentinel lymph node biopsy Cervical cancer is one of the most preventable cancers worldwide – and yet over 340,000 women die from it every year. In the period 2025/2026, several developments have fundamentally changed...… CME-Test
View Post 5 min This content is machine translated Asthma during pregnancy Up to 40% suffer worsening of symptoms during pregnancy Asthma is one of the most common chronic diseases during pregnancy. Despite this, targeted research in this area remains relatively limited and translation into optimal maternal care remains a challenge....…
View Post 7 min This content is machine translated HER2+ metastatic breast cancer New therapeutic standards with SHR-A 1811 This year’s ESMO Congress 2025 once again offered a wide range of new data on the treatment of HER2-positive breast cancer, including the interim analysis of the phase 3 HORIZON-Breast01...…
View Post 5 min This content is machine translated Gestational diabetes Significant CVD prevention through five lifestyle factors Cardiovascular disease (CVD) is a major cause of morbidity and mortality in women worldwide, particularly those with adverse pregnancy outcomes such as gestational diabetes (GD). Although GD is an established...…
View Post 6 min This content is machine translated Oncology Study updates from the ESMO Congress The variety of topics presented at the congress of the European Society for Medical Oncology (ESMO) last October underlined the breadth of the field and the close interlinking of disciplines....…
View Post 6 min This content is machine translated Hormone balance and longevity Ageing is not a substitution diagnosis In the longevity debate, “hormone balance” is often used as a synonym for “biologically younger”. Clinically, the term is only meaningful if it is linked to clearly defined axial disorders,...…
View Post 17 min This content is machine translated Low grade serous ovarian carcinoma (LGSOC) Opening up new horizons through combination therapies This year’s congress of the European Society for Medical Oncology , which took place in Berlin from October 17 to 21, 2025, offered an impressive variety of topics on numerous...…
View Post 5 min This content is machine translated Study report: TBS v3 and v4 in comparison Analysis of OsteoLaus study data The OsteoLaus study is part of the prospective, population-based CoLaus/PsyColaus study of postmenopausal women in Switzerland. In an analysis published in Osteoporosis International in 2025, the Trabecular Bone Score (TBS)...…
